DPP4 and retinal disorder: Cross-talk between advanced glycation end products (AGE) and their receptors (RAGE) with the dipeptidyl peptidase-4 (DPP-4)-incretin system has been implicated in the pathogenesis of a number of diabetic complications, including retinopathy, nephropathy, and atherosclerosis [34, 35].